{"id":"https://openalex.org/W3015537792","doi":"https://doi.org/10.1177/1078155220913098","title":"A survey of global biosimilar implementation practice conducted by the International Society of Oncology Pharmacy Practitioners","display_name":"A survey of global biosimilar implementation practice conducted by the International Society of Oncology Pharmacy Practitioners","publication_year":2020,"publication_date":"2020-04-01","ids":{"openalex":"https://openalex.org/W3015537792","doi":"https://doi.org/10.1177/1078155220913098","mag":"3015537792","pmid":"https://pubmed.ncbi.nlm.nih.gov/32268828"},"language":"en","primary_location":{"id":"doi:10.1177/1078155220913098","doi":"https://doi.org/10.1177/1078155220913098","is_oa":true,"landing_page_url":"https://doi.org/10.1177/1078155220913098","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/1078155220913098","source":{"id":"https://openalex.org/S66425452","display_name":"Journal of Oncology Pharmacy Practice","issn_l":"1078-1552","issn":["1078-1552","1477-092X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Oncology Pharmacy Practice","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://journals.sagepub.com/doi/pdf/10.1177/1078155220913098","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062028521","display_name":"Emma Foreman","orcid":"https://orcid.org/0000-0002-4348-9040","observed_orcids":["https://orcid.org/0000-0002-4348-9040"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Emma Foreman","raw_affiliation_strings":["Royal Marsden NHS Foundation Trust, London, UK"],"raw_orcid":"https://orcid.org/0000-0002-4348-9040","affiliations":[{"raw_affiliation_string":"Royal Marsden NHS Foundation Trust, London, UK","institution_ids":["https://openalex.org/I1325846038"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015398786","display_name":"Himanshu J. Patel","orcid":"https://orcid.org/0000-0002-7240-6857","observed_orcids":["https://orcid.org/0000-0002-7240-6857"]},"institutions":[{"id":"https://openalex.org/I4405279011","display_name":"International Society of Oncology Pharmacy Practitioners","ror":"https://ror.org/00wwmz516","country_code":"CA","type":"nonprofit","lineage":["https://openalex.org/I4405279011"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Himanshu Patel","raw_affiliation_strings":["Chair of ISOPP Education Committee, International Society of Oncology Pharmacy Practitioners, Vancouver, Canada"],"raw_orcid":"https://orcid.org/0000-0002-7240-6857","affiliations":[{"raw_affiliation_string":"Chair of ISOPP Education Committee, International Society of Oncology Pharmacy Practitioners, Vancouver, Canada","institution_ids":["https://openalex.org/I4405279011"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034986062","display_name":"Jim Siderov","orcid":"https://orcid.org/0000-0002-9562-083X","observed_orcids":["https://orcid.org/0000-0002-9562-083X"]},"institutions":[{"id":"https://openalex.org/I4210163497","display_name":"Austin Health","ror":"https://ror.org/05dbj6g52","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210163497"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Jim Siderov","raw_affiliation_strings":["Austin Health, Victoria, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Austin Health, Victoria, Australia","institution_ids":["https://openalex.org/I4210163497"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085394313","display_name":"Jatinder Harchowal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jatinder Harchowal","raw_affiliation_strings":["Royal Marsden NHS Foundation Trust, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Marsden NHS Foundation Trust, London, UK","institution_ids":["https://openalex.org/I1325846038"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041785705","display_name":"Joseph S. Bubalo","orcid":"https://orcid.org/0000-0002-7873-1597","observed_orcids":["https://orcid.org/0000-0002-7873-1597"]},"institutions":[{"id":"https://openalex.org/I4210143859","display_name":"Oregon Health and Science University Hospital","ror":"https://ror.org/0488bnd65","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210143859"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph Bubalo","raw_affiliation_strings":["Department of Pharmacy, Oregon Health and Science University Hospital, Portland, OR, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Oregon Health and Science University Hospital, Portland, OR, USA","institution_ids":["https://openalex.org/I4210143859"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5060981830","display_name":"Alexandre Chan","orcid":"https://orcid.org/0000-0003-4391-4219","observed_orcids":["https://orcid.org/0000-0003-4391-4219"]},"institutions":[{"id":"https://openalex.org/I165932596","display_name":"National University of Singapore","ror":"https://ror.org/01tgyzw49","country_code":"SG","type":"education","lineage":["https://openalex.org/I165932596"]}],"countries":["SG"],"is_corresponding":false,"raw_author_name":"Alexandre Chan","raw_affiliation_strings":["National University of Singapore, Singapore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National University of Singapore, Singapore","institution_ids":["https://openalex.org/I165932596"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5062028521"],"corresponding_institution_ids":["https://openalex.org/I1325846038"],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":null,"fwci":0.4371,"has_fulltext":true,"cited_by_count":15,"citation_normalized_percentile":{"value":0.55862231,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"26","issue":"3_suppl","first_page":"22","last_page":"32"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9854000210762024,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9854000210762024,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.014100000262260437,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/biosimilars","display_name":"biosimilars","score":0.9940000176429749},{"id":"https://openalex.org/keywords/oncology-pharmacy-practice","display_name":"oncology pharmacy practice","score":0.8190000057220459},{"id":"https://openalex.org/keywords/oncology-pharmacists","display_name":"oncology pharmacists","score":0.8849999904632568},{"id":"https://openalex.org/keywords/drug-costs","display_name":"drug costs","score":0.5479999780654907},{"id":"https://openalex.org/keywords/insurance-coverage","display_name":"insurance coverage","score":0.4359999895095825},{"id":"https://openalex.org/keywords/professional-education-and-training","display_name":"professional education and training","score":0.6759999990463257}],"concepts":[{"id":"https://openalex.org/C59491497","wikidata":"https://www.wikidata.org/wiki/Q864715","display_name":"Biosimilar","level":2,"score":0.9840371012687683},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7719417214393616},{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.7315402030944824},{"id":"https://openalex.org/C39896193","wikidata":"https://www.wikidata.org/wiki/Q380344","display_name":"Descriptive statistics","level":2,"score":0.5901881456375122},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.5166173577308655},{"id":"https://openalex.org/C509550671","wikidata":"https://www.wikidata.org/wiki/Q126945","display_name":"Medical education","level":1,"score":0.37722694873809814},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23979079723358154},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.0},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D003430","descriptor_name":"Cross-Sectional Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010593","descriptor_name":"Pharmaceutical Services","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D010595","descriptor_name":"Pharmacists","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D011795","descriptor_name":"Surveys and Questionnaires","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059451","descriptor_name":"Biosimilar Pharmaceuticals","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1177/1078155220913098","doi":"https://doi.org/10.1177/1078155220913098","is_oa":true,"landing_page_url":"https://doi.org/10.1177/1078155220913098","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/1078155220913098","source":{"id":"https://openalex.org/S66425452","display_name":"Journal of Oncology Pharmacy Practice","issn_l":"1078-1552","issn":["1078-1552","1477-092X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Oncology Pharmacy Practice","raw_type":"journal-article"},{"id":"pmid:32268828","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32268828","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1177/1078155220913098","doi":"https://doi.org/10.1177/1078155220913098","is_oa":true,"landing_page_url":"https://doi.org/10.1177/1078155220913098","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/1078155220913098","source":{"id":"https://openalex.org/S66425452","display_name":"Journal of Oncology Pharmacy Practice","issn_l":"1078-1552","issn":["1078-1552","1477-092X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Oncology Pharmacy Practice","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.766700029373169,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3015537792.pdf","grobid_xml":"https://content.openalex.org/works/W3015537792.grobid-xml"},"referenced_works_count":16,"referenced_works":["https://openalex.org/W1514585260","https://openalex.org/W1751328374","https://openalex.org/W2403703304","https://openalex.org/W2521239893","https://openalex.org/W2558625543","https://openalex.org/W2606204120","https://openalex.org/W2765216186","https://openalex.org/W2907088970","https://openalex.org/W2913657514","https://openalex.org/W2919830364","https://openalex.org/W2940698006","https://openalex.org/W2965938015","https://openalex.org/W2969256165","https://openalex.org/W2985005368","https://openalex.org/W3015742209","https://openalex.org/W3015948821"],"related_works":["https://openalex.org/W3015948821","https://openalex.org/W4282822171","https://openalex.org/W4286297758","https://openalex.org/W4390766272","https://openalex.org/W3179678083","https://openalex.org/W4307362415","https://openalex.org/W3215150641","https://openalex.org/W4412812926","https://openalex.org/W4393408744","https://openalex.org/W3140972611"],"abstract_inverted_index":{"Background:":[0],"The":[1,99,168,250],"International":[2],"Society":[3],"of":[4,83,88,106,138,179,214,223,243,252,270,274],"Oncology":[5],"Pharmacy":[6],"Practitioners":[7],"(ISOPP)":[8],"Biosimilars":[9],"Task":[10],"Force":[11],"was":[12,72],"charged":[13],"to":[14,20,43,95,115,130,165,176,204,216,220,230,237],"develop":[15],"educational":[16],"activities":[17],"and":[18,54,78,85,104,118,194,240,261,278],"resources":[19],"assist":[21],"members":[22,50,141,146],"when":[23,61],"implementing":[24],"biosimilar":[25,45,116,181,205,239],"medicines":[26],"into":[27,64],"their":[28,65,208],"local":[29],"practice.":[30,67],"To":[31],"facilitate":[32],"the":[33,35,52,55,97,123,132,160,163,174,202,221,241,256,268,272],"process,":[34],"task":[36],"force":[37],"conducted":[38,73],"a":[39,86,148,180,212,228,238,279],"survey":[40,71,100,133,254],"in":[41,159,267],"order":[42],"understand":[44],"implementation":[46,117,120,206],"practice":[47,113,121],"by":[48,184],"ISOPP":[49,84,140],"across":[51],"world":[53],"challenges":[56],"that":[57,172],"oncology":[58,90],"pharmacists":[59],"face":[60],"adopting":[62],"biosimilars":[63,218],"clinical":[66,191],"Methods:":[68],"A":[69,136],"cross-sectional":[70],"between":[74],"20":[75],"April":[76],"2019":[77],"27":[79],"May":[80],"2019.":[81],"Members":[82],"number":[87],"national":[89],"pharmacy":[91],"groups":[92],"were":[93,128,142],"invited":[94],"complete":[96],"survey.":[98],"contained":[101],"29":[102],"items":[103],"consisted":[105],"three":[107],"sections:":[108],"respondents\u2019":[109,111,124],"demographics,":[110],"institutional":[112],"relating":[114],"post":[119],"at":[122,207],"institutions.":[125],"Descriptive":[126],"statistics":[127],"utilized":[129],"analyze":[131],"results.":[134],"Results:":[135],"total":[137,164],"265":[139],"surveyed,":[143],"with":[144],"50":[145],"providing":[147],"response":[149],"(response":[150],"rate":[151],"=":[152],"19%).":[153],"In":[154],"addition,":[155],"40":[156],"nonmembers":[157],"participated":[158],"survey,":[161],"bringing":[162],"90":[166],"respondents.":[167],"most":[169],"common":[170],"factors":[171],"influence":[173],"decision":[175],"implement":[177],"use":[178,217,269],"as":[182],"reported":[183],"respondents":[185],"are":[186],"medication":[187],"costs/pricing":[188],"(92%),":[189],"available":[190],"data":[192],"(73%),":[193],"product":[195],"availability":[196],"(63%).":[197],"Respondents":[198],"also":[199],"commented":[200],"on":[201],"barriers":[203],"institutions,":[209],"which":[210],"included":[211],"reluctance":[213,229],"prescribers":[215],"(due":[219],"lack":[222],"familiarity":[224],"or":[225,246],"perceived":[226],"inferiority),":[227],"switch":[231],"established":[232],"patients":[233],"from":[234],"an":[235],"originator":[236],"preferences":[242],"insurance":[244],"companies":[245],"funding":[247],"bodies.":[248],"Conclusion:":[249],"results":[251],"this":[253],"reinforce":[255],"need":[257,280],"for":[258,263,281],"greater":[259],"education":[260],"training":[262],"health":[264],"care":[265],"professionals":[266],"biosimilars,":[271],"importance":[273],"sharing":[275],"good":[276],"practice,":[277],"standardization.":[282]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":6},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2020-04-17T00:00:00"}